CN Patent

CN119868330A — 在进食状态下具有改善的药代动力学的γ-羟基丁酸酯组合物

Assigned to Flamel Ireland Ltd · Expires 2025-04-25 · 1y expired

What this patent protects

提供当进食后不到两小时施用时具有改善的药代动力学性质的羟丁酸钠口服药物组合物及其治疗用途。

USPTO Abstract

提供当进食后不到两小时施用时具有改善的药代动力学性质的羟丁酸钠口服药物组合物及其治疗用途。

Drugs covered by this patent

sodium-oxybate (SODIUM OXYBATE)

Patent Metadata

Patent number: CN119868330A
Jurisdiction: CN
Classification: —
Expires: 2025-04-25
Drug substance claim: No
Drug product claim: No
Assignee: Flamel Ireland Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.